Academic · Private company
Tisch Multiple Sclerosis Research Center of New York
Track this companyFree. Adds Tisch Multiple Sclerosis Research Center of New York to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials2
- Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple SclerosisPHASE2 · COMPLETED · started Sep 21, 2018ClinicalTrials.gov NCT03355365 · fetched Nov 12, 2026
- Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple SclerosisNO_LONGER_AVAILABLEClinicalTrials.gov NCT03822858 · fetched Nov 12, 2026